Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies

Background: Proton pump inhibitor (PPI) is commonly used in patients with cirrhosis. However, some studies demonstrated that PPI use was associated with adverse outcome in patients with cirrhosis. We aimed to perform a meta-analysis of cohort studies to evaluate the association between PPI use and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoli, Zhang, Daofu, Yu, Yuexiao, Lou, Lianqing, Li, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Gastrointestinal, Renal & Hepatic Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276520/
https://www.ncbi.nlm.nih.gov/pubmed/32406491
http://dx.doi.org/10.1042/BSR20193890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276520/
https://www.ncbi.nlm.nih.gov/pubmed/32406491
http://dx.doi.org/10.1042/BSR20193890

Ejemplares similares